After meeting with the FDA, the makers of intravenous meloxicam plan to resubmit the treatment’s new drug application…
Allopurinol for Gout an Unlikely Contributor to Kidney Disease
NEW YORK (Reuters Health)—Allopurinol does not appear to contribute to decline in kidney function and may actually protect renal function in patients with gout, according to a large population-based study. Gout affects around 4% of Americans and often occurs alongside chronic kidney disease (CKD), Dr. Tuhina Neogi from Boston University School of Medicine and colleagues…
More Evidence TNF Inhibitors Raise Risk of Peripheral Neuropathy
NEW YORK (Reuters Health)—A large epidemiological study provides more evidence of a link between tumor necrosis factor inhibitors (TNFi) and peripheral neuropathy (PN). “These events are rare and the benefit of these drugs still outweigh this risk so this should not change practice,” cautions first author Dr. Mahyar Etminan from the University of British Columbia…
Rheumatologists’ Pay Increases for 3rd Year in a Row
Although compensation in the U.S. healthcare system still favors procedure-based specialties, rheumatologists have seen a pay raise over the past three years, according to the 2018 Medscape Physician Compensation Report…
Taking Vitamin D Supplements May Not Improve Bone Health
(Reuters Health)—Vitamin D supplementation may not improve bone density or prevent fractures and falls in adults, a large new analysis suggests. After combining data from 81 randomized controlled trials, researchers found no bone benefits from supplementing the vitamin, according to the report in The Lancet Diabetes & Endocrinology, online October 4. “Our results show that…
Antidepressant of No Clear Value in Chronic Low-Back Pain
NEW YORK (Reuters Health)—Low-dose amitriptyline does not have clear benefits for patients with chronic low-back pain that has no specific cause, according to results from a randomized clinical trial. Despite the lack of evidence that antidepressants are more effective than placebo for low-back pain, seven of 14 national and international guidelines recommend their use in…
Trio Wins Chemistry Nobel for Work on Antibody Drugs & Detergents
STOCKHOLM/LONDON (Reuters)—Two Americans and a Briton won the 2018 Nobel Prize for Chemistry on Wednesday for harnessing the power of evolution to generate novel proteins used in everything from environmentally friendly detergents and biofuels to cancer drugs. The fruits of this work include the world’s top-selling prescription medicine – the antibody injection Humira sold by…
Reap the Rewards of State Society Involvement
Getting involved with your state society offers many benefits, from personal pride and group engagement, to “promoting good ideas, as well as stopping bad ideas from becoming laws that can harm your patients,” says Robert Levin, MD, immediate past president of the Florida Society of Rheumatology (FSR). That’s why he has been involved in leadership…
RISE Lifts Research: The 2018 Annual Meeting Features 6 New Studies Based on RISE Data
Data from the ACR’s Rheumatology Informatics System for Effectiveness (RISE) were used by rheumatology researchers in a crop of new studies that will be presented at the 2018 ACR/ARHP Annual Meeting, Oct. 19–24 in Chicago. Six abstracts, including four oral and two poster presentations, were accepted for this year’s meeting. They explore topics ranging from…
RISE Dashboard Updates Help Users Report 2018 MIPS Data
As the year begins to wind down, Zach McMurray is gearing up for 2018 MIPS reporting. Despite the “always changing and usually confusing landscape of MACRA/MIPS,” he says his practice isn’t worried because it uses the ACR’s Rheumatology Informatics System for Effectiveness (RISE) qualified clinical data registry. Mr. McMurray is director of clinical information systems…
- « Previous Page
- 1
- …
- 308
- 309
- 310
- 311
- 312
- …
- 814
- Next Page »